Today BLPL in-house development products are being registered in various countries In Middle East, Baltic Regions & Latin America and plans to license out to major pharmaceutical companies in Europe, Australia, & South Africa are being worked out. Our competitive edge is characterized by cost efficient   development and production, creative marketing and added value customer service. Through strategic partnerships, including but not limited to Licensing   or distribution agreements, our international activities are expanding to more than 15 countries worldwide.

This has been accomplished through the talent and dedication of our employees who align their goals with the needs of our customers and partners, as well as the needs and requirements of each market.  In parallel, BLPL is investing on the introduction of value added health care products in Anti Malarial & Anti Cancer in the local market. With an extensive product portfolio and an experienced sales force &   backward integration, BLPL intends to become a leader in anti Malarial & Anti Cancer products and one of   the fastest growing pharmaceutical companies in India.